pharmaceutical

Class 05: Pharmaceutical Trademarks?

Filing Activity Analysis: Supplements on the rise The 11th (2020) Edition of the Nice Classification describes Class 5 as “mainly pharmaceuticals and other preparations for medical or veterinary purposes”. When most people hear the word “pharmaceuticals” in the context of trademarks, they think of traditional areas of medicine such as cancer, vaccines, antibiotics, diabetes and […]

Pharma disruptors, challenges and opportunities

The recent Financial Times Global Pharmaceutical and Biotechnology Conference provided two days of fascinating insights into the pharma industry, with discussions around the key challenges, disruptors and opportunities it is facing. Covering topics ranging from artificial intelligence to alternative funding options, and patient-centered care to pricing, the meeting brought together experts from across the healthcare […]

Diverse approaches in immuno-oncology

A fascinating range of insights into the ways in which the immune system can be harnessed to fight cancer was provided by Global Engage’s Immuno-Oncology Research & Technology Series meeting this month in London. The conference comprised five concurrent tracks covering cutting-edge developments in fields such as cell therapies, novel antibodies and neoantigens. Some of […]

Overcoming key challenges in drug naming

The global market for pharmaceutical products reached $1.2 trillion in 2018 – up $100 billion from the prior year. It is projected to reach $1.5 trillion by 2023.[1] By another measure, this translates into more than 40,000 Class 5 trademark applications submitted to Trademark Offices around the world in 2018, on top of 300,000+ already […]